Influence of Additional Physician's Consultations and Short Message Service (SMS) Reminders to Patient Compliance

The League of Clinical Research, Russia2,912 enrolled

Overview

A systematic collection of retrospective and prospective data based on non-interventional patient observation, aimed to assess the risks, course and outcomes of a disease or a group of diseases: * the retrospective part: database of patients with cardiovascular risks; * the prospective part: observation of patients in the real world medical practice.

The research program will have two parts: Stage 1: identification of patients with moderate, high and very high cardiovascular risk, not having diseases of atherosclerotic genesis and requiring lipid-lowering drugs. Stage 2: a prospective observation of patients receiving primary medical prophylaxis of CVD with atorvastatin.

Study Type

OBSERVATIONAL

Enrollment

2,912

Conditions

Lipid Metabolism Disorders

Interventions

atorvastatinDRUG

Profound patients' consultations (different from standard practice) on the importance of primary prevention of cardiovascular diseases, including preventive administration of statins. Subjects in profound consultation group will receive regular reminders (2 times a month) via SMS and phone calls to check following the doctor's recommendations and remind about follow-up visit to study centre.

Eligibility

Sex: ALLMin age: 40 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion criteria: Data on the following subjects is planned to be collected in the project: * Aged from 40 to 65 years inclusively * With a high (≥5%) cardiovascular risk measured by SCORE and low density lipoprotein (LDL) levels of ≥2,5 mmol/L, or with a very high (≥10%) cardiovascular risk measured by SCORE and LDL levels ≥1,8 mmol/L or With atherosclerotic stenosis of brachiocephalic arteries of \>50% in the absence of cerebrovascular disease Exclusion criteria: * No contraindications to statin treatment and not taking stating at study entry. * History of the following clinically significant events and conditions: (а) myocardial infarction (б) stroke (в) transient ischemic attack * Presence of the following diseases at the time of a statin administration: (а) ischemic heart disease (б) heart failure (в) peripheral artery atherosclerosis (г) atherosclerotic stenosis of brachiocephalic arteries with cerebrovascular disease . Subjects must give their consent for processing of their personal data for the purposes of this scientific project.

Locations (1)

League of Clinical Research (LeagueCRR)

Moscow, Russia

Outcomes

Primary Outcomes

Target level of LDL cholesterol

To assess number of patients achieving the target level of low-density lipoprotein cholesterol in study group and in control group.

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.